AIMC Topic: Neuromuscular Agents

Clear Filters Showing 11 to 14 of 14 articles

Assessment of artificial intelligence performance in answering questions on onabotulinum toxin and sacral neuromodulation.

Investigative and clinical urology
PURPOSE: This study aimed to evaluate the performance of three artificial intelligence (AI) models-ChatGPT, Gemini, and Copilot-in addressing clinically relevant questions about onabotulinum toxin and sacral neuromodulation (SNM) for the management o...

Evaluating the Impact of BoNT-A Injections on Facial Expressions: A Deep Learning Analysis.

Aesthetic surgery journal
BACKGROUND: Botulinum toxin type A (BoNT-A) injections are widely administered for facial rejuvenation, but their effects on facial expressions remain unclear.

Clinical Uses of a Robot (Hybrid-Assisted Limb or HALâ„¢) in Patients with Post-stroke Spasticity after Botulinum Toxin Injections.

The journal of medical investigation : JMI
Spasticity is the major cause of disabilities in stroke-survivors. Botulinum neurotoxin (BoNT) injections have been used to reduce the muscle tone in those patients, but its efficacy in functional outcome is not well delineated. We have studied the e...

[Efficacy of Botulinum-A toxin injection into bladder to treat neurogenic incontinence in patients with spinal cord injury: comparison of two doses].

Zhonghua yi xue za zhi
OBJECTIVE: To evaluate the efficacy of Botulinum-A toxin injection into bladder to treat neurogenic incontinence in patients with spinal cord injury and compare effectiveness of two different doses (200 U and 300 U).